Mandatory notification of acquisition of shares by primary insider
18 May 2022 16:00 CEST
Issuer
NYKODE THERAPEUTICS ASA
Oslo, Norway, May 18, 2022 - Primary insider Martin Nicklasson, Chair of the
Board of Nykode Therapeutics AS, has today acquired 10,000 shares in Nykode
Therapeutics AS at a price of NOK 32.05 per share. Following the transaction,
Martin Nicklasson holds 32,000 shares in Nykode Therapeutics AS.
Please see further details in the attached document.
More information:
Access the news on Oslo Bors NewsWeb site
Source
Nykode Therapeutics AS
Provider
Oslo Børs Newspoint
Company Name
NYKODE THERAPEUTICS ASA
ISIN
NO0010714785
Symbol
NYKD
Market
Oslo Børs